 |
|
|
| |
The clinical relevance of potential drug-drug interactions (DDIs) with bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) - Real-world data from the German IQVIA prescription database
|
| |
| |
Glaasgow 2020 Oct 5-8 virtual
Reported by Jules Levin
Tim Umland1, Hans-Jürgen Stellbrink2, Marta Calvo3, Astrid Zahn3
1Alexander Apotheke, Hamburg, Germany; 2Infektionsmedizinisches Centrum Hamburg (ICH), Hamburg, Germany; 3Gilead Sciences GmbH, Munich, Germany
|
| |
|
|
|
|
|
